Suppr超能文献

宫内节育器在哺乳期女性中的安全性:一项系统评价。

The safety of intrauterine devices in breastfeeding women: a systematic review.

作者信息

Berry-Bibee Erin N, Tepper Naomi K, Jatlaoui Tara C, Whiteman Maura K, Jamieson Denise J, Curtis Kathryn M

机构信息

Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA, USA.

出版信息

Contraception. 2016 Dec;94(6):725-738. doi: 10.1016/j.contraception.2016.07.006. Epub 2016 Jul 13.

Abstract

OBJECTIVES

To investigate levonorgestrel (LNG)-releasing and copper-bearing (Cu) intrauterine device (IUD) safety among breastfeeding women and, for Cu-IUD use, breastfeeding performance and infant health.

STUDY DESIGN

Systematic review.

METHODS

We searched PubMed, Embase, Cochrane Library and clinicaltrials.gov for articles through January 2016. We included studies of Cu-IUD or LNG-IUD users comparing IUD-specific (perforation, expulsion) and other contraceptive-related (infection, removal/cessation due to bleeding/pain and other adverse events) outcomes for breastfeeding vs. non-breastfeeding women. We also included studies of breastfeeding women comparing contraceptive-related outcome for IUD-users vs. other contraceptive-method users. Finally, we included studies comparing breastfeeding outcomes among Cu-IUD users to users of other nonhormonal contraceptives or no contraception.

RESULTS

Of 548 articles identified, 23 (16 studies) met the inclusion criteria. Two studies suggested that the risk of IUD perforation was 6-10 times higher among breastfeeding vs. non-breastfeeding women. Seven studies suggested that risks for other adverse events were similar or lower among breastfeeding vs. non-breastfeeding women. Three studies among breastfeeding women found no increased risk of adverse events in IUD users vs. nonusers. Breastfeeding performance and infant growth were similar for Cu-IUD users and users of other nonhormonal methods or no contraception.

CONCLUSION

Overall, risks for adverse events among IUD users, including expulsion, pain and removals, were similar or lower for breastfeeding women vs. non-breastfeeding women. Uterine perforation with IUDs, while rare, appeared more frequent among breastfeeding women. No evidence indicated that Cu-IUD use in breastfeeding women influences breastfeeding performance or infant growth.

摘要

目的

调查含左炔诺孕酮(LNG)和含铜(Cu)宫内节育器(IUD)在哺乳期妇女中的安全性,以及对于使用Cu-IUD的情况,调查其对母乳喂养及婴儿健康的影响。

研究设计

系统评价。

方法

我们检索了截至2016年1月的PubMed、Embase、Cochrane图书馆及clinicaltrials.gov上的文章。我们纳入了关于Cu-IUD或LNG-IUD使用者的研究,比较了哺乳期与非哺乳期妇女在IUD特异性(穿孔、脱落)及其他与避孕相关(感染、因出血/疼痛及其他不良事件而取出/停用)结局方面的差异。我们还纳入了关于哺乳期妇女的研究,比较了IUD使用者与其他避孕方法使用者在避孕相关结局方面的差异。最后,我们纳入了比较Cu-IUD使用者与其他非激素避孕方法使用者或未避孕者在母乳喂养结局方面的差异的研究。

结果

在检索到的548篇文章中,23篇(16项研究)符合纳入标准。两项研究表明,哺乳期妇女IUD穿孔的风险比非哺乳期妇女高6至10倍。七项研究表明,哺乳期妇女在其他不良事件方面的风险与非哺乳期妇女相似或更低。三项针对哺乳期妇女的研究发现,IUD使用者与非使用者相比,不良事件风险并未增加。Cu-IUD使用者与其他非激素方法使用者或未避孕者在母乳喂养表现及婴儿生长方面相似。

结论

总体而言,IUD使用者(包括脱落、疼痛和取出)的不良事件风险在哺乳期妇女中与非哺乳期妇女相似或更低。IUD导致的子宫穿孔虽罕见,但在哺乳期妇女中似乎更常见。没有证据表明哺乳期妇女使用Cu-IUD会影响母乳喂养表现或婴儿生长。

相似文献

1
The safety of intrauterine devices in breastfeeding women: a systematic review.
Contraception. 2016 Dec;94(6):725-738. doi: 10.1016/j.contraception.2016.07.006. Epub 2016 Jul 13.
2
The safety of intrauterine devices among young women: a systematic review.
Contraception. 2017 Jan;95(1):17-39. doi: 10.1016/j.contraception.2016.10.006. Epub 2016 Oct 19.
4
Intrauterine device use among women with uterine fibroids: a systematic review.
Contraception. 2010 Jul;82(1):41-55. doi: 10.1016/j.contraception.2010.02.011. Epub 2010 Mar 29.
5
Interventions for emergency contraception.
Cochrane Database Syst Rev. 2017 Aug 2;8(8):CD001324. doi: 10.1002/14651858.CD001324.pub5.
6
Hormonal contraception for women at risk of HIV infection.
Cochrane Database Syst Rev. 2025 Jun 6;6(6):CD015701. doi: 10.1002/14651858.CD015701.pub2.
8
Interventions to prevent or treat heavy menstrual bleeding or pain associated with intrauterine-device use.
Cochrane Database Syst Rev. 2022 Aug 26;8(8):CD006034. doi: 10.1002/14651858.CD006034.pub3.
9
Immediate versus delayed postpartum insertion of contraceptive implant and IUD for contraception.
Cochrane Database Syst Rev. 2022 Oct 27;10(10):CD011913. doi: 10.1002/14651858.CD011913.pub3.
10
Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery.
Cochrane Database Syst Rev. 2021 Dec 20;12(12):CD005072. doi: 10.1002/14651858.CD005072.pub4.

引用本文的文献

1
Risk factors of uterine perforation when using contraceptive intrauterine devices.
BMC Womens Health. 2024 Sep 27;24(1):538. doi: 10.1186/s12905-024-03298-3.
2
U.S. Medical Eligibility Criteria for Contraceptive Use, 2024.
MMWR Recomm Rep. 2024 Aug 8;73(4):1-126. doi: 10.15585/mmwr.rr7304a1.
3
Uterine Perforation by Levonorgestrel-Releasing Intrauterine Device: A Case Report.
Cureus. 2022 Nov 12;14(11):e31398. doi: 10.7759/cureus.31398. eCollection 2022 Nov.
5
Migration of intrauterine device caused asymptomatic acute appendicitis: A case report.
Clin Case Rep. 2021 May 24;9(5):e04283. doi: 10.1002/ccr3.4283. eCollection 2021 May.
6
Clinical Evaluation of Li Brush Endometrial Samplers for Diagnosing Endometrial Lesions in Women With Intrauterine Devices.
Front Med (Lausanne). 2020 Nov 30;7:598689. doi: 10.3389/fmed.2020.598689. eCollection 2020.
7
Barriers to post-placental intrauterine device receipt among expectant minority women.
Eur J Contracept Reprod Health Care. 2021 Apr;26(2):91-97. doi: 10.1080/13625187.2020.1852398. Epub 2020 Dec 9.
8
Postpartum intrauterine device placement: a patient-friendly option.
Contracept Reprod Med. 2018 Apr 15;3:3. doi: 10.1186/s40834-018-0057-x. eCollection 2018.
9
Long-Acting Reversible Contraception.
N Engl J Med. 2017 Feb 2;376(5):461-468. doi: 10.1056/NEJMcp1608736.
10
Removing medical barriers to contraception - evidence-based recommendations from the Centers for Disease Control and Prevention, 2016.
Contraception. 2016 Dec;94(6):579-581. doi: 10.1016/j.contraception.2016.08.007. Epub 2016 Aug 30.

本文引用的文献

1
Immediate postpartum provision of long-acting reversible contraception.
Curr Opin Obstet Gynecol. 2015 Dec;27(6):460-4. doi: 10.1097/GCO.0000000000000224.
2
Lactational amenorrhoea method for family planning.
Cochrane Database Syst Rev. 2015 Oct 12;2015(10):CD001329. doi: 10.1002/14651858.CD001329.pub2.
3
Progestogen-only contraceptive use among breastfeeding women: a systematic review.
Contraception. 2016 Sep;94(3):226-52. doi: 10.1016/j.contraception.2015.09.010. Epub 2015 Sep 26.
5
Immediate postpartum insertion of intrauterine device for contraception.
Cochrane Database Syst Rev. 2015 Jun 26;2015(6):CD003036. doi: 10.1002/14651858.CD003036.pub3.
7
Intrauterine device insertion in the postpartum period: a systematic review.
Eur J Contracept Reprod Health Care. 2015 Feb;20(1):4-18. doi: 10.3109/13625187.2014.971454. Epub 2014 Nov 14.
8
Breastfeeding and the use of human milk.
Pediatrics. 2012 Mar;129(3):e827-41. doi: 10.1542/peds.2011-3552. Epub 2012 Feb 27.
10
U S. Medical Eligibility Criteria for Contraceptive Use, 2010.
MMWR Recomm Rep. 2010 Jun 18;59(RR-4):1-86.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验